Evidence map›Paper›PMID 30244381›Full record

ArticleHeart and vessels2019

The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril study.

Andreas Jekell, Majid Kalani, Thomas Kahan

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Heart and vessels, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02901977 (On the Antithrombotic Effects of Doxazosin and Ramipril in Essential Hypertension), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02901977 phase4completednot on this map

On the Antithrombotic Effects of Doxazosin and Ramipril in Essential Hypertension

TypeinterventionalSponsorKarolinska InstitutetRan2011 to 2015Enrolled71ConditionsHypertensionArmsRamipril, Doxazosin
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Markers of Vascular Dysfunction in Hypertension.Current medicinal chemistry · 2025
    Review
  6. Article
  7. Research Progress and Clinical Value of Subendocardial Viability Ratio.Journal of the American Heart Association · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Andreas JekellDivision of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 182 88, Stockholm, Sweden. andreas.jekell@sll.se.ORCID http://orcid.org/0000-0002-3898-0839
Majid KalaniDivision of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 182 88, Stockholm, Sweden.
Thomas KahanDivision of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 182 88, Stockholm, Sweden.
Danderyds sjukhus · SEKarolinska Institutet · SE

Funding

Hjärt-Lungfonden 20130467Karolinska Institutet 2014FoBi41054
6 · The paper itself

Abstract

There are several non-invasive methods to study endothelial function, but their interrelation and association to cardiovascular risk have not been well evaluated. We studied macrovascular and microvascular endothelial function simultaneously in different vascular beds in relation to cardiovascular mortality risk (Systematic Coronary Risk Evaluation, SCORE) and hypertension induced cardiac organ damage, and their interrelationship. The study investigated 71 hypertensive patients by forearm post-ischemic flow-mediated vasodilation, pulse wave analysis (applanation tonometry) and beta 2-adrenoceptor agonist stimulation for changes in reflection index, skin microvascular reactivity by laser Doppler fluxmetry with iontophoresis and heat-induced hyperaemia, and coronary microvascular function by subendocardial viability ratio (derived from pulse wave analysis). Flow mediated vasodilation related inversely to SCORE (r =  0.34, P = 0.011). Adding microalbuminuria and pulse wave velocity strengthened the associations. Pulse wave reflection changes did not relate to SCORE. Skin microvascular reactivity related inversely to SCORE (peak flux change to sodium nitroprusside r =  0.29, P = 0.033, and to heating r =  0.31, P = 0.018). Subendocardial viability ratio did not relate to SCORE. Endothelial function indices showed no consistent relation to cardiac target organ damage. The agreement between the different methods for evaluating indices of macrovascular and microvascular endothelial function was weak. In conclusion, indices of macrovascular and microvascular endothelial function relate to cardiovascular mortality risk. Their use may improve cardiovascular risk prediction in hypertension. However, methods representing different vascular beds show little interrelationship and are not interchangeable, which may depend on different pathogenetic mechanisms representing different aspects of future cardiovascular risk.Trial registry: NCT02901977.

Indexed as

Adrenergic alpha-1 Receptor AntagonistsAdultAgedAngiotensin-Converting Enzyme InhibitorsBlood PressureDoxazosinEchocardiographyEndothelium, VascularFemaleFollow-Up StudiesHumansHypertensionLaser-Doppler FlowmetryMaleMicrocirculationMiddle AgedAdrenergic alpha-1 Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsDoxazosinRamiprilCardiac hypertrophyEndothelial functionHypertensionPrognosisSCORESkin microcirculation

Identifiers

PMID30244381
PMCPMC6373355
OpenAlexW2893207955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.